Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Luisa Fernanda Castillo-León"'
Publikováno v:
Journal of Pregnancy, Vol 2022 (2022)
Preeclampsia (PE) is a hypertensive disease that affects pregnant women after 20 weeks of gestation. This disease is associated with an important risk of maternal and fetal mortality. PE is described as a placental pathology because, after delivery,
Externí odkaz:
https://doaj.org/article/a80377103fb3413a8215838b92b11f0e
Publikováno v:
Journal of pregnancy. 2022
Preeclampsia (PE) is a hypertensive disease that affects pregnant women after 20 weeks of gestation. This disease is associated with an important risk of maternal and fetal mortality. PE is described as a placental pathology because, after delivery,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1aa0c2905595836499e2d335d85bf26
https://pubmed.ncbi.nlm.nih.gov/35198246
https://pubmed.ncbi.nlm.nih.gov/35198246
Autor:
Mariana, Angulo-Aguado, Karen, Panche, Caroll Andrea, Tamayo-Agudelo, Daniel-Armando, Ruiz-Torres, Santiago, Sambracos-Parrado, Maria Jose, Niño-Orrego, Nathaly, Páez, Laura B, Piñeros-Hernandez, Luisa-Fernanda, Castillo-León, Juan Mauricio, Pardo-Oviedo, Katherine Parra, Abaunza, Paul, Laissue, Nora, Contreras, Carlos Alberto, Calderón-Ospina, Dora Janeth, Fonseca-Mendoza
Publikováno v:
Journal of Personalized Medicine
Clopidogrel, an oral platelet P2Y12 receptor blocker, is used in the treatment of acute coronary syndrome. Interindividual variability in treatment response and the occurrence of adverse effects has been attributed to genetic variants in CYP2C19. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4a1ee31e5a1ed075b0b1a37549111fb
https://pubmed.ncbi.nlm.nih.gov/34065778
https://pubmed.ncbi.nlm.nih.gov/34065778
Autor:
Nora Contreras, Nathaly Páez, Dora Janeth Fonseca-Mendoza, Caroll Tamayo-Agudelo, Santiago Sambracos-Parrado, Juan Mauricio Pardo-Oviedo, Karen Panche, Maria Jose Niño-Orrego, Katherine Parra Abaunza, Daniel Armando Ruiz-Torres, Laura B. Piñeros-Hernández, Carlos Alberto Calderón-Ospina, Luisa Fernanda Castillo-León, Paul Laissue, Mariana Angulo-Aguado
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 400, p 400 (2021)
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 400, p 400 (2021)
Clopidogrel, an oral platelet P2Y12 receptor blocker, is used in the treatment of acute coronary syndrome. Interindividual variability in treatment response and the occurrence of adverse effects has been attributed to genetic variants in CYP2C19. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e7cb13ebce266d996f1e4c1e7b384b
https://doi.org/10.3390/jpm11050400
https://doi.org/10.3390/jpm11050400